Industry Verticals »

All Categories

Insights »

About TMR »

Small Animal Imaging Market

Small Animal Imaging Market (Micro-CT, Micro-MRI, Micro-PET/SPECT, Multimodal, Micro-Ultrasound and Micro-PAT) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2020

Small animal imaging market comprises the devices and reagents used for preclinical imaging of rats and mice for drug development and gene expression studies. These devices are similar to imaging modalities used for diagnostic purposes in humans, however due to the smaller size are generally referred as micro devices such as micro-MRI, micro-SPECT and others. Anatomical, molecular and functional analysis in pre-imaging can provide valuable information to understand the activity of pharmaceutical compounds in preclinical or phase I stage. Such visualization and analysis help and support supporting studies evaluating APIs activity as well as its safety and toxicity.
 
Being a non-invasive technique, longitudinal studies are possible in preclinical imaging with accurate and detailed analysis. The global small animal imaging market has been studied from three main perspectives: by devices, by reagents, and by application areas. Various devices in the preclinical imaging market include micro-computed tomography (CT), micro-magnetic resonance imaging (MRI), micro-positron emission tomography (PET), single positron emission computed tomography (SPECT), multimodal imaging, optical imaging, micro-ultrasound imaging and micro-photoacoustic tomography (PAT). The contrast reagents market comprises reagents used in CT, MRI, nuclear imaging, optical imaging and ultrasound imaging technologies. The market with respect to major application areas is studied for oncology, cardiology, autoimmune diseases, neurology & psychiatry and others. Since the inception of the market micro-CT and micro-MRI devices have well established themselves in the market. However the multimodal and optical imaging market are the fastest growing in the global small animal imaging market. In the contrast reagents market optical imaging reagents is the fastest growing market owing to increasing number of gene expression studies. In optical imaging reagents, fluorescent-labeled contrast agents have shown to be useful and safe alternatives to radiotracers in preclinical imaging studies. 
 
The preclinical imaging market has gone through myriad technological advancements and increase in research funding which has exponentially grown the market. Prominent factors driving the global small animal imaging market include growing installation base of multimodal and optical imaging market across the globe. Additionally the increasing demand for preclinical CROs market in Asia Pacific and other developing parts of the world have also boosted the growth in last one decade. High development cost leading to slow adoption rate and restricted accessibility to nuclear imaging reagents are among the few restraints to the market. Over the years the reagents market is expected to grow at a rapid pace due to frequent purchase, high shelf life of devices limiting the frequent purchase and growing number of reagent manufacturers. Companies should focus on improving MRI based multimodal imaging devices such as PET/MRI devices is likely to open extensive growth opportunities in the forthcoming years.
 
Geographically the market is largely dominated by North America followed by Europe due to frequent product launches, increasing preclinical research activities and high adoption rate for expensive devices. Asia Pacific and Rest of the World are among the fastest growing market due to growing number of CROs and increasing industry based funding for conducting pharmaceutical based preclinical researches. The global small animal imaging market has consolidated in the past few years. Some of the prominent players profiled in the report include Agilent Technologies, Inc., Aspect Imaging, Bruker Corporation, TriFoil Imaging, Inc., LI-COR Biosciences, Inc., Miltenyi Biotec GmbH, Perkin Elmer, Inc., Promega Corporation, Siemens AG, SCANCO Medical AG and Targeson, Inc. 
    Chapter 1 Introduction
    1.1 Report Description
    1.2 Market Segmentation
    1.3 Research Methodology
           1.3.1 Secondary Research
           1.3.2 Primary Research
    1.4 List of Abbreviations
    1.5 Assumptions and Stipulations
     
    Chapter 2 Executive Summary
     
    Chapter 3 Global Small Animal Imaging (In-Vivo) Market Overview
    3.1 Market Definition and Overview
    3.2 Market Dynamics
           3.2.1 Market Drivers
                    3.2.1.1 Growing applications of preclinical imaging modalities in drug discovery and biotechnology research is increasing the installed base of small animal imaging devices
                    3.2.1.2 Exponential growth and demand for CROs in emerging market propelling preclinical imaging devices and contrast agents
                    3.2.1.3 Increasing adoption of multimodal and optical imaging devices due to cost effectiveness and easy handling
           3.2.2 Restraints
                   3.2.2.1 High device development cost and multiple approvals hindering the growth of the market
                   3.2.2.2 Long shelf life of preclinical imaging devices is likely to lead to early saturation of the devices market
           3.2.3 Opportunities
                    3.2.3.1 Investment in developing novel reagents would lead to sustainable growth in the preclinical imaging market
    3.3 Porter’s Five Forces Analysis for the Global Small Animal Imaging (In –Vivo) Market
           3.3.1 Bargaining Power of Suppliers
           3.3.2 Bargaining Power of Buyers
           3.3.3 Threats of Substitutes
           3.3.4 Threat of New Entrants
           3.3.5 Competitive Rivalry
    3.4 Value Chain Analysis: Global Small Animal Imaging (In-Vivo) Market
    3.5 Market Attractiveness Analysis of the Global Small Animal Imaging (In-Vivo) Market, by Geography, 2013
    3.6 Market Share Analysis: Global Small Animal Imaging (In-Vivo) Market, by Key Players, 2013
     
    Chapter 4 Global Small Animal Imaging (In-Vivo) Market, by Devices
    4.1 Introduction
           4.1.1 Global Small Animal Imaging (In-Vivo) Market Revenue, by Devices, 2012 - 2020 (USD Million)
    4.2 Micro-CT Imaging
           4.2.1 Global Micro-CT Imaging Market Revenue, 2012 - 2020 (USD Million)
    4.3 Micro-MRI Imaging
           4.3.1 Global Micro-MRI Imaging Market Revenue, 2012 - 2020 (USD Million)
    4.4 Micro-PET/SPECT Imaging
           4.4.1 Global Micro-PET/SPECT Imaging Market Revenue, 2012 - 2020 (USD Million)
    4.5 Multimodal Imaging
           4.5.1 Global Multimodal Imaging Market Revenue, 2012 - 2020 (USD Million)
    4.6 Optical Imaging
           4.6.1 Global Optical Imaging Systems Market Revenue, 2012 - 2020 (USD Million)
    4.7 Micro-Ultrasound Imaging
           4.7.1 Global Micro-Ultrasound Imaging Market Revenue, 2012 - 2020 (USD Million)
    4.8 Micro-PAT Imaging
           4.8.1 Global Micro-PAT Imaging Market Revenue, 2012 - 2020 (USD Million)
     
    Chapter 5 Global Small Animal Imaging (In-Vivo) Market, by Reagents
    5.1 Introduction
           5.1.1 Global Small Animal Imaging (In-Vivo) Market Revenue, by Reagents, 2012 - 2020 (USD Million)
    5.2 Computed Tomography (CT) Contrast Reagents
           5.2.1 Global CT Contrast Reagents Market Revenue, 2012 - 2020 (USD Million)
    5.3 MRI Contrast Reagents
           5.3.1 Global MRI Contrast Reagents Market Revenue, 2012 - 2020 (USD Million)
    5.4 Nuclear Imaging Contrast Reagents
           5.4.1 Global Nuclear Imaging Contrast Reagents Market Revenue, 2012 - 2020 (USD Million)
    5.5 Optical Imaging Contrast Reagents
           5.5.1 Global Optical Imaging Contrast Reagents Market Revenue, 2012 - 2020 (USD Million)
    5.6 Ultrasound Contrast Reagents
           5.6.1 Global Ultrasound Contrast Reagents Market Revenue, 2012 - 2020 (USD Million)
     
    Chapter 6 Global Small Animal Imaging (In-Vivo) Market, by Major Application Areas
    6.1 Introduction
           6.1.1 Global Small Animal Imaging (In-Vivo) Market Revenue, by Major Application Areas, 2012 - 2020 (USD Million)
    6.2 Oncology
           6.2.1 Global Small Animal Imaging Market Revenue, by Oncology Application, 2012 - 2020 (USD Million)
    6.3 Cardiology
           6.3.1 Global Small Animal Imaging Market Revenue, by Cardiology Application, 2012 - 2020 (USD Million)
    6.4 Autoimmune Disease
           6.4.1 Global Small Animal Imaging Market Revenue, by Autoimmune Diseases Application, 2012 - 2020 (USD Million)
    6.5 Neurology and Psychiatry
           6.5.1 Global Small Animal Imaging Market Revenue, by Neurology and Psychiatry Application, 2012 - 2020 (USD Million)
    6.6 Other Applications (Metabolic Disorders, Pulmonary Disorders and Infectious Diseases)
           6.6.1 Global Small Animal Imaging Market Revenue, by Other Applications (Metabolic Disorders, Pulmonary Disorders and Infectious Diseases), 2012 - 2020 (USD Million)
     
    Chapter 7 Global Small Animal Imaging (In-Vivo) Market, by Geography
    7.1 Introduction
           7.1.1 Global Small Animal Imaging (In-Vivo) Market Revenue, by Geography, 2012 - 2020 (USD Million)
    7.2 North America
           7.2.1 North America Small Animal Imaging Market Revenue, 2012-2020 (USD Million)
    7.3 Europe
           7.3.1 Europe Small Animal Imaging Market Revenue, 2012-2020 (USD Million)
    7.4 Asia Pacific
           7.4.1 Asia Pacific Small Animal Imaging Market Revenue, 2012-2020 (USD Million)
    7.5 Rest of the World
           7.5.1 Rest of the World Small Animal Imaging Market Revenue, 2012 - 2020 (USD Million)
     
    Chapter 8 Recommendations
    8.1 Focus on Developing MRI Based Multimodal Devices
    8.2 Increasing Investments and Research in Contrast Reagents Segment to Address Constant Consumption and High Returns
     
    Chapter 9 Company Profiles
    9.1 Agilent Technologies, Inc.
           9.1.1 Company Overview
           9.1.2 Financial Overview
           9.1.3 Product Portfolio
           9.1.4 Business Strategies
           9.1.5 Recent Developments
    9.2 Aspect Imaging
           9.2.1 Company Overview
           9.2.2 Financial Overview
           9.2.3 Product Portfolio
           9.2.4 Business Strategies
           9.2.5 Recent Developments
    9.3 Bruker Corporation
           9.3.1 Company Overview
           9.3.2 Financial Overview
           9.3.3 Product Portfolio
           9.3.4 Business Strategies
           9.3.5 Recent Developments
    9.4 TriFoil Imaging, Inc.
           9.4.1 Company Overview
           9.4.2 Financial Overview
           9.4.3 Product Portfolio
           9.4.4 Business Strategies
           9.4.5 Recent Developments
    9.5 LI-COR Biosciences, Inc.
           9.5.1 Company Overview
           9.5.2 Financial Overview
           9.5.3 Product Portfolio
           9.5.4 Business Strategies
           9.5.5 Recent Developments
    9.6 FujiFilm VisualSonics, Inc.
           9.6.1 Company Overview
           9.6.2 Financial Overview
           9.6.3 Product Portfolio
           9.6.4 Business Strategies
           9.6.5 Recent Developments
    9.7 Miltenyi Biotec GmbH
           9.7.1 Company Overview
           9.7.2 Financial Overview
           9.7.3 Product Portfolio
           9.7.4 Business Strategies
           9.7.5 Recent Developments
    9.8 Perkin Elmer, Inc.
           9.8.1 Company Overview
           9.8.2 Financial Overview
           9.8.3 Product Portfolio
           9.8.4 Business Strategies
           9.8.5 Recent Developments
    9.9 Promega Corporation
           9.9.1 Company Overview
           9.9.2 Financial Overview
           9.9.3 Product Portfolio
           9.9.4 Business Strategies
           9.9.5 Recent Developments
    9.10 Siemens AG
           9.10.1 Company Overview
           9.10.2 Financial Overview
           9.10.3 Product Portfolio
           9.10.4 Business Strategies
           9.10.5 Recent Developments
    9.11 SCANCO Medical AG
           9.11.1 Company Overview
           9.11.2 Financial Overview
           9.11.3 Product Portfolio
           9.11.4 Business Strategies
           9.11.5 Recent Developments
    9.12 Targeson, Inc.
           9.12.1 Company Overview
           9.12.2 Financial Overview
           9.12.3 Product Portfolio
           9.12.4 Business Strategies
           9.12.5 Recent Developments
    List of Tables
     
    TABLE 1 Market Snapshot: Global Small Animal Imaging Market
    TABLE 2 Clinical Research Outsourcing Opportunities in China
    TABLE 3 Global Small Animal Imaging (In-Vivo) Market Revenue, by Devices, 2012 - 2020 (USD Million)
    TABLE 4 Global Small Animal Imaging (In-Vivo) Market Revenue, by Reagents, 2012 - 2020 (USD Million)
    TABLE 5 Global Small Animal Imaging (In-Vivo) Market Revenue, by Major Application Areas, 2012 - 2020 (USD Million)
    TABLE 6 Global Small Animal Imaging (In-Vivo) Market Revenue, by Geography, 2012 - 2020 (USD Million)

    List of Figures

     

    FIG. 1 Small Animal Imaging Market: Market Segmentation

    FIG. 2 Global Small Animal Imaging Market, by Devices, 2013 (USD Million)

    FIG. 3 Porter’s Five Forces Analysis: Global Small Animal Imaging (In-Vivo) Market

    FIG. 4 Value Chain Analysis: Global Small Animal Imaging (In-Vivo) Market

    FIG. 5 Market Attractiveness Analysis: Global Small Animal Imaging (In-Vivo) Market, by Geography, 2013

    FIG. 6 Market Share Analysis: Global Small Animal Imaging (In-Vivo) Market, by Key Players, 2013 (Value%)

    FIG. 7 Global Micro-CT Imaging Market Revenue, 2012 - 2020 (USD Million)

    FIG. 8 Global Micro-MRI Imaging Market Revenue, 2012 - 2020 (USD Million)

    FIG. 9 Global Micro-PET/SPECT Imaging Market Revenue, 2012 - 2020 (USD Million)

    FIG. 10 Global Multimodal Imaging Market Revenue, 2012 - 2020 (USD Million)

    FIG. 11 Global Optical Imaging Services Market Revenue, 2012 - 2020 (USD Million)

    FIG. 12 Global Micro-Ultrasound Imaging Market Revenue, 2012 - 2020 (USD Million)

    FIG. 13 Global Micro-PAT Imaging Market Revenue, 2012 - 2020 (USD Million)

    FIG. 14 Global CT Contrast Reagents Market Revenue, 2012 - 2020 (USD Million)

    FIG. 15 Global MRI Contrast Reagents Market Revenue, 2012 - 2020 (USD Million)

    FIG. 16 Global Nuclear Imaging Contrast Reagents Market Revenue, 2012 - 2020 (USD Million)

    FIG. 17 Global Optical Imaging Contrast Reagents Market Revenue, 2012 - 2020 (USD Million)

    FIG. 18 Global Ultrasound Contrast Reagents Market Revenue, 2012 - 2020 (USD Million)

    FIG. 19 Global Small Animal Imaging Market Revenue, by Oncology Application, 2012 - 2020 (USD Million)

    FIG. 20 Global Small Animal Imaging Market Revenue, by Cardiology Application, 2012 - 2020 (USD Million)

    FIG. 21 Global Small Animal Imaging Market Revenue, by Autoimmune Diseases Application, 2012 - 2020 (USD Million)

    FIG. 22 Global Small Animal Imaging Market Revenue, by Neurology and Psychiatry Application, 2012 - 2020 (USD Million)

    FIG. 23 Global Small Animal Imaging Market Revenue, by Other Applications (Metabolic Disorders, Pulmonary Disorders and Infectious Diseases), 2012 - 2020 (USD Million)

    FIG. 24 North America Small Animal Imaging Market Revenue, 2012 - 2020 (USD Million)

    FIG. 25 Europe Small Animal Imaging Market Revenue, 2012 - 2020 (USD Million)

    FIG. 26 Asia Pacific Small Animal Imaging Market Revenue, 2012 - 2020 (USD Million)

    FIG. 27 Rest of the World Small Animal Imaging Market Revenue, 2012 - 2020 (USD Million)

    FIG. 28 Agilent Technologies, Inc.: Annual Report, 2011 – 2013 (USD Million)

    FIG. 29 Bruker Corporation: Annual Report, 2011 – 2013 (USD Million)

    FIG. 30 FUJIFILM Holdings, Medical Systems and Life Sciences Segment: Annual Report, 2011 – 2013 (USD Million)

    FIG. 31 Perkin Elmer, Inc.: Annual Report, 2011 – 2013 (USD Million)

    FIG. 32 Siemens AG, Healthcare Segment: Annual Report, 2011 – 2013 (USD Million)

Copyright © Transparency Market Research, Inc. All Rights reserved

Small Animal Imaging Market

Schedule a Call